Keyphrases
Action Potential Amplitude
19%
AIDS/HIV
26%
Amyotrophic Lateral Sclerosis
16%
Antiretroviral Therapy
20%
Autosomal Dominant
19%
Cerebrospinal Fluid
32%
Clinical Features
45%
Cognitive Impairment
26%
Compound muscle Action Potential
27%
Duchenne muscular Dystrophy
19%
Dynein
17%
Electrodiagnosis
23%
Electromyography
28%
Frontotemporal Dementia
17%
Hereditary Myopathy
26%
HIV-associated Neurocognitive Disorders
42%
Immunosuppression
16%
Inflammation
19%
Late-onset
26%
Latency
26%
M Protein
19%
Median Nerve
29%
Muscle Biopsy
33%
Muscle Fiber
31%
Muscle Pathology
16%
Myasthenia Gravis
23%
Myelopathy
17%
Myopathic
23%
Myopathy
87%
Nerve
18%
Nerve Conduction Studies
33%
Neurological Examination
27%
Neuromuscular Disease
19%
Neuropathy
22%
Novel mutation
23%
Pathological Features
26%
Peripheral Nerve
17%
Peripheral Neuropathy
47%
Polyneuropathy
33%
Prednisone
27%
Recurrent Laryngeal Nerve
29%
Recurrent Laryngeal Nerve Injury
17%
Rituximab
26%
Serum IgM
45%
Skeletal muscle
39%
Spinal muscular Atrophy
39%
Spinal muscular Atrophy with Lower Extremity Predominance
21%
Target Antigen
16%
TS-HDS
21%
Waldenström Macroglobulinemia
27%
Neuroscience
Action Potential
14%
Afferent Nerve Fiber
13%
Amyotrophic Lateral Sclerosis
25%
Autoantibodies
21%
Axon
14%
Central Nervous System
15%
Cholinergic Receptor Antibody
13%
Cognitive Disorders
13%
Cognitive Function
13%
Creatine Kinase
18%
Cytoplasmic Dynein
13%
Disaccharide
14%
Electrodiagnosis
18%
Frontotemporal Dementia
17%
Heavy Chain
13%
Heparin
13%
Human Immunodeficiency Virus
55%
Human Immunodeficiency Virus Proteinase
13%
Immunoglobulin M
63%
Immunoglobulin M Antibody
14%
Immunosuppression
16%
Median Nerve
17%
Methylprednisolone
13%
Motor Neuron Disease
14%
Motor Unit
27%
Muscle Disorder
96%
Muscular Dystrophy
23%
Myasthenia gravis
21%
Nerve Conduction Study
20%
Neuromuscular Disorder
12%
Neuropathy
100%
Paraprotein
13%
Peripheral Nerve
29%
Peripheral Nervous System
13%
Placebo
12%
Polyneuropathy
61%
Prednisone
30%
Proteinase
13%
Rituximab
26%
Sarcoglycan
13%
Sensory Nerve
13%
Septin
13%
Serotonin Reuptake Inhibitor
13%
Signal Recognition Particle
13%
Spinal Muscular Atrophy
26%
Sporadic Creutzfeldt Jakob Disease
13%
Statin
13%
TAR DNA Binding Protein
13%
Transmembrane Protein
13%
Ulnar Nerve
17%
Medicine and Dentistry
Action Potential
18%
Action Potential Duration
13%
Amyloid Protein
13%
Antiviral Activity
13%
Autoantibodies
13%
Biopsy Technique
20%
Carpal Tunnel Syndrome
23%
Central Nervous System
16%
Chronic Inflammatory Demyelinating Polyneuropathy
13%
Clinical Trial
14%
Cohort Analysis
14%
Connective Tissue
22%
Diagnosis
14%
Disaccharide
14%
Diseases
17%
Electrodiagnosis
14%
Electromyography
30%
Gene Linkage
13%
Glycogen Storage Disease Type II
16%
Human Immunodeficiency Virus
38%
Immunity
21%
Immunoglobulin M
43%
Immunosuppressive Treatment
16%
Innervation
14%
Median Nerve
26%
Motor Unit
26%
Muscle Biopsy
18%
Myopathy
73%
Möbius Syndrome
13%
Neck
18%
Nerve Conduction
13%
Nerve Conduction Study
30%
Neuropathy
31%
Nonsense Mutation
13%
Peripheral Nerve
14%
Polyradiculoneuropathy
24%
Prednisone
26%
Recurrent Laryngeal Nerve
30%
Recurrent Laryngeal Nerve Injury
17%
Red Blood Cell Indices
13%
Reuptake Inhibitor
13%
Sarcoglycan
13%
Sensory Neuropathy
26%
Skeletal Muscle
26%
Spinal Muscular Atrophy
26%
Statin
13%
Ulnar Nerve
19%
Ultrasonography of Muscle
13%
Waldenström's Macroglobulinemia
17%
Weakness
81%